[Gestrinone in pelvic endometriosis. A one-year evaluation].

The therapeutical effectiveness of gestrinone in endometriosis treatment, as well as its long term side effects, were evaluated. Prospective, clinical trial. At "Dr. Alejandro Castanedo Kimball" Hospital (PEMEX). Salamanca, Guanajuato. México. Thirty women with laparoscopically confirmed endometriosis, were studied. Subjects received 2.5 mg. of gestrinone two times per week for 6 months. Laparoscopy was performed before treatment, and clinical response was determined by second laparoscopy after 6 months. The pregnancy rate, frequency of side effects and recurrence of symptoms were determined. Median total endometriosis scores and symptoms decreased significantly after treatment. Four pregnancies were observed after treatment. The principal side effects were: ponderal increase, changes in the voice and hirsutism. However, the side effects disappeared after one year of clinical survey. The results indicate that gestrinone is effective in the treatment of pelvic endometriosis. In despite of a clear benefic effect on stage of the disease and symptoms; the use of gestrinone should weigh the risk-benefit (cost versus metabolic side effects) of treatment.
AuthorsE Cervantes Villarreal, H R García Zamarripa, E Herrera Prado, J Barrón Vallejo
JournalGinecología y obstetricia de México (Ginecol Obstet Mex) Vol. 63 Pg. 328-30 (Aug 1995) ISSN: 0300-9041 [Print] MEXICO
Vernacular TitleGestrinona en endometriosis pélvica. Evaluación a unaño.
PMID7672647 (Publication Type: Clinical Trial, Clinical Trial, Phase II, English Abstract, Journal Article)
Chemical References
  • Contraceptive Agents, Female
  • Gestrinone
  • Adolescent
  • Adult
  • Contraceptive Agents, Female (administration & dosage, adverse effects)
  • Dose-Response Relationship, Drug
  • Endometriosis (diagnosis, drug therapy, physiopathology)
  • Female
  • Gestrinone (administration & dosage, adverse effects)
  • Humans
  • Laparoscopy
  • Pelvic Pain (drug therapy, etiology)
  • Pelvis (physiopathology)
  • Pregnancy
  • Prospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: